NCT02295202View on ClinicalTrials.gov

Impact of Obstructive Sleep Apnea Treatment in Patients With Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

December 31, 2019

Conditions
Sleep ApneaMetabolic Syndrome
Interventions
DEVICE

CPAP (REMstar System One Plus - Philips Medical Systems)

Standard device for treating obstructive sleep apnea.

DEVICE

Nasal strips

Trial Locations (1)

Unknown

Luciano Drager, São Paulo

Sponsors

Collaborators (1)

Fleury
All Listed Sponsors
collaborator

Fleury

UNKNOWN

lead

University of Sao Paulo

OTHER

NCT02295202 - Impact of Obstructive Sleep Apnea Treatment in Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter